Both in Pharmaceuticals
Alkermes vs Kiniksa Pharmaceuticals International
Over the past year ALKS returned +51.0% and KNSA returned +149.4%; their daily moves had a correlation of 0.12.
ALKS +51.0% KNSA +149.4%Growth of $1, one year, split-adjusted
| Metric | ALKS | KNSA |
|---|---|---|
| Price | $45.89 | $96.12 |
| Market cap | $7.70B | $7.55B |
| Today | +0.44% | +3.03% |
| 1 month | +10.2% | +24.7% |
| 6 months | +29.9% | +65.1% |
| Year to date | +64.0% | +133.0% |
| 1 year | +52.1% | +156.5% |
| Revenue growth (YoY) | +21.8% | +58.1% |
| Gross margin | 80.4% | 90.3% |
| Net margin | 3.4% | 16.6% |
| P/E (TTM) | — | 68.9× |
| Price / sales | 4.4× | 8.0× |
| Net cash | -$742.3M | $462.9M |
| Dividend yield | — | — |
| Volatility (60d) | 31.7% | 54.2% |
| Short % of float | 11.5% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).